Recombinant Influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)) Hemagglutinin Protein (HA1 Subunit) (His Tag) Antigens The N-terminal segment (Met 1-Arg 345) of theinfluenza hemagglutinin (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2))(ADI52838.1), termed as HA1, was expressed with a C-terminal polyhistidine tag. The secreted recombinant HA1 subunit of influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2)) comprises 340a.a and has a predicted molecular weight of 38.1 kDa. It migrates as an approximately 58-68 kDa band in SDS-PAGE under reducing conditions.
$ $99 In stock
Formulation: The secreted recombinant HA1 subunit of influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2)) comprises 340a.a and has a predicted molecular weight of 38.1 kDa. It migrates as an approximately 58-68 kDa band in SDS-PAGE under reducing conditions.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.

Recombinant Influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)) Hemagglutinin Protein (HA1 Subunit) (His Tag)

The product is for non-human research only. Not for therapeutic or veterinary use.

Catalog No: bt-224461

Molecular Weight: The secreted recombinant HA1 subunit of influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2)) comprises 340a.a and has a predicted molecular weight of 38.1 kDa. It migrates as an approximately 58-68 kDa band in SDS-PAGE under reducing conditions.

Formulation: Recombinant Influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)) Hemagglutinin Protein was lyophilized from sterile PBS, pH 7.4.1.

Source: HEK293 Cells

Product Name Recombinant Influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)) Hemagglutinin Protein (HA1 Subunit) (His Tag)
AA Sequence Met 1-Arg 345
Bioactivity Please contact us for detailed information
Description The N-terminal segment (Met 1-Arg 345) of theinfluenza hemagglutinin (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2))(ADI52838.1), termed as HA1, was expressed with a C-terminal polyhistidine tag.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method
Formulation Recombinant Influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)) Hemagglutinin Protein was lyophilized from sterile PBS, pH 7.4.1.
Molecular Weight The secreted recombinant HA1 subunit of influenza A H3N2 (A/reassortant/IVR-155(Victoria/210/2009 x Puerto Rico/8/1934)(H3N2)) comprises 340a.a and has a predicted molecular weight of 38.1 kDa. It migrates as an approximately 58-68 kDa band in SDS-PAGE under reducing conditions.
Product Background The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer.HA has at least 18 different antigens. These subtypes are named H1 through H18.HA has two functions. Firstly, it allows the recognition of target vertebrate cells, accomplished through the binding to these cells' sialic acid-containing receptors. Secondly, once bound it facilitates the entry of the viral genome into the target cells by causing the fusion of host endosomal membrane with the viral membrane.The influenza virus Hemagglutinin (HA) protein is translated in cells as a single protein, HA, or hemagglutinin precursor protein. For viral activation, hemagglutinin precursor protein (HA) must be cleaved by a trypsin-like serine endoprotease at a specific site, normally coded for by a single basic amino acid (usually arginine) between the HA1 and HA2 domains of the protein. After cleavage, the two disulfide-bonded protein domains produce the mature form of the protein subunits as a prerequisite for the conformational change necessary for fusion and hence viral infectivity.
Product Type Antigen
Purity Greater than 95% as determined by SDS-PAGE
Source HEK293 Cells
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Terminal Gln 17
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.